Been daydreaming about my son's future...

NoExcuses

New member
Being 20 years old and with an FEV1 over 80% is fantastic.

Generally an FEV1 between 75-100% is considered mild.

In terms of hope for a cure in 10 years. I was told when I was 9 in 1990 when the gene was discovered that my CF would be cured by the time I went to college. That was 8 years ago.....

There are some therapies in the pipeline for CF (as we know for every drug that is FDA approved about 10 more are rejected by the FDA or don't make it through safety/efficacy trials). So as long as <b> everyone makes a huge effort to particpate in clinical trials </b> (Dr. Beall of the CF Foundation is extremely worried that not enough CF patients will volunteer for these studies so it will take even longer for drugs to get to CFErs) I think we might have a shot at some good drugs in the next 10 years.

As always, I hope my perspective is wrong. I would be overjoyed if it is. But until now, I remain reserved.
 

NoExcuses

New member
Being 20 years old and with an FEV1 over 80% is fantastic.

Generally an FEV1 between 75-100% is considered mild.

In terms of hope for a cure in 10 years. I was told when I was 9 in 1990 when the gene was discovered that my CF would be cured by the time I went to college. That was 8 years ago.....

There are some therapies in the pipeline for CF (as we know for every drug that is FDA approved about 10 more are rejected by the FDA or don't make it through safety/efficacy trials). So as long as <b> everyone makes a huge effort to particpate in clinical trials </b> (Dr. Beall of the CF Foundation is extremely worried that not enough CF patients will volunteer for these studies so it will take even longer for drugs to get to CFErs) I think we might have a shot at some good drugs in the next 10 years.

As always, I hope my perspective is wrong. I would be overjoyed if it is. But until now, I remain reserved.
 

NoExcuses

New member
Being 20 years old and with an FEV1 over 80% is fantastic.

Generally an FEV1 between 75-100% is considered mild.

In terms of hope for a cure in 10 years. I was told when I was 9 in 1990 when the gene was discovered that my CF would be cured by the time I went to college. That was 8 years ago.....

There are some therapies in the pipeline for CF (as we know for every drug that is FDA approved about 10 more are rejected by the FDA or don't make it through safety/efficacy trials). So as long as <b> everyone makes a huge effort to particpate in clinical trials </b> (Dr. Beall of the CF Foundation is extremely worried that not enough CF patients will volunteer for these studies so it will take even longer for drugs to get to CFErs) I think we might have a shot at some good drugs in the next 10 years.

As always, I hope my perspective is wrong. I would be overjoyed if it is. But until now, I remain reserved.
 

NoExcuses

New member
Being 20 years old and with an FEV1 over 80% is fantastic.

Generally an FEV1 between 75-100% is considered mild.

In terms of hope for a cure in 10 years. I was told when I was 9 in 1990 when the gene was discovered that my CF would be cured by the time I went to college. That was 8 years ago.....

There are some therapies in the pipeline for CF (as we know for every drug that is FDA approved about 10 more are rejected by the FDA or don't make it through safety/efficacy trials). So as long as <b> everyone makes a huge effort to particpate in clinical trials </b> (Dr. Beall of the CF Foundation is extremely worried that not enough CF patients will volunteer for these studies so it will take even longer for drugs to get to CFErs) I think we might have a shot at some good drugs in the next 10 years.

As always, I hope my perspective is wrong. I would be overjoyed if it is. But until now, I remain reserved.
 

spacemom

New member
Oh my. What does it take for labs and research ppl increase and hasten the research???
Money? I'm not rich but I'd be willing to give a little! Awareness? Pressure? We could sign petitions too!!
There is not only the pain of the disease but also the sensation of impotence before it.
Rats, so much spent on weapons of war and ... well let me not get started on this. <img src="i/expressions/face-icon-small-sad.gif" border="0">
 

spacemom

New member
Oh my. What does it take for labs and research ppl increase and hasten the research???
Money? I'm not rich but I'd be willing to give a little! Awareness? Pressure? We could sign petitions too!!
There is not only the pain of the disease but also the sensation of impotence before it.
Rats, so much spent on weapons of war and ... well let me not get started on this. <img src="i/expressions/face-icon-small-sad.gif" border="0">
 

spacemom

New member
Oh my. What does it take for labs and research ppl increase and hasten the research???
Money? I'm not rich but I'd be willing to give a little! Awareness? Pressure? We could sign petitions too!!
There is not only the pain of the disease but also the sensation of impotence before it.
Rats, so much spent on weapons of war and ... well let me not get started on this. <img src="i/expressions/face-icon-small-sad.gif" border="0">
 

spacemom

New member
Oh my. What does it take for labs and research ppl increase and hasten the research???
Money? I'm not rich but I'd be willing to give a little! Awareness? Pressure? We could sign petitions too!!
There is not only the pain of the disease but also the sensation of impotence before it.
Rats, so much spent on weapons of war and ... well let me not get started on this. <img src="i/expressions/face-icon-small-sad.gif" border="0">
 

spacemom

New member
Oh my. What does it take for labs and research ppl increase and hasten the research???
Money? I'm not rich but I'd be willing to give a little! Awareness? Pressure? We could sign petitions too!!
There is not only the pain of the disease but also the sensation of impotence before it.
Rats, so much spent on weapons of war and ... well let me not get started on this. <img src="i/expressions/face-icon-small-sad.gif" border="0">
 

spacemom

New member
Oh my. What does it take for labs and research ppl increase and hasten the research???
Money? I'm not rich but I'd be willing to give a little! Awareness? Pressure? We could sign petitions too!!
There is not only the pain of the disease but also the sensation of impotence before it.
Rats, so much spent on weapons of war and ... well let me not get started on this. <img src="i/expressions/face-icon-small-sad.gif" border="0">
 

rvm1212

New member
HI!
I have to say that I don´t agree with Amy when she sais "There isn't because genes don't predict how long you'll live. They simply don't. ".
How can you be so confident on that?? It´s difficult for me to think that a genetic disease progress has nothing to do with the type of gene you have. I know there are some articles where it sais that they couldn´t find that relationship yet. But that doesn´t mean it doesn´t exist. We don´t know much about cf genes yet to say that. Also there are some articles as the following one that don´t agree with that. By these I don´t mean that other things like exercise, chest therapy etc are not importat. I think it´s just a mix of everything.
I really hope a cure will be found soo. Let´s hope denufosol trial goes fine!!<img src="i/expressions/face-icon-small-smile.gif" border="0">



1: Thorax. 2005 Jul;60(7):558-63. Links
Genotype-phenotype correlation for pulmonary function in cystic fibrosis.de Gracia J, Mata F, Alvarez A, Casals T, Gatner S, Vendrell M, de la Rosa D, Guarner L, Hermosilla E.
Department of Pneumology, Hospital general Vall d'Hebron, Barcelona, Spain. jgracia@separ.es

BACKGROUND: Since the CFTR gene was cloned, more than 1000 mutations have been identified. To date, a clear relationship has not been established between genotype and the progression of lung damage. A study was undertaken of the relationship between genotype, progression of lung disease, and survival in adult patients with cystic fibrosis (CF). METHODS: A prospective cohort of adult patients with CF and two CFTR mutations followed up in an adult cystic fibrosis unit was analysed. Patients were classified according to functional effects of classes of CFTR mutations and were grouped based on the CFTR molecular position on the epithelial cell surface (I-II/I-II, I-II/III-V). Spirometric values, progression of lung disease, probability of survival, and clinical characteristics were analysed between groups. RESULTS: Seventy four patients were included in the study. Patients with genotype I-II/I-II had significantly lower current spirometric values (p < 0.001), greater loss of pulmonary function (p < 0.04), a higher proportion of end-stage lung disease (p < 0.001), a higher risk of suffering from moderate to severe lung disease (odds ratio 7.12 (95% CI 1.3 to 40.5)) and a lower probability of survival than patients with genotype I-II/III, I-II/IV and I-II/V (p < 0.001). CONCLUSIONS: <b><u><u>The presence of class I or II mutations on both chromosomes is associated with worse respiratory disease and a lower probability of survival</u></u></b>.

PMID: 15994263 [PubMed - indexed for MEDLINE]

Related LinksEuropean Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. [Pediatr Pulmonol. 2001]Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients. [Eur Respir J. 1996]Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. [Pediatrics. 2005]Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. [Lancet. 2003]Cystic fibrosis mutations and genotype-pulmonary phenotype analysis. [J Cyst Fibros. 2006]See all Related Articles...
Display SummaryBriefAbstractAbstractPlusCitationMEDLINEXMLUI ListLinkOutASN.1Related ArticlesCited ArticlesCited in BooksCancerChrom LinksDomain Links3D Domain LinksGEO DataSet LinksGene LinksGene (GeneRIF) LinksGenome LinksProject LinksGENSAT LinksGEO Profile LinksHomoloGene LinksCoreNucleotide LinksCoreNucleotide (RefSeq) LinksEST LinksEST (RefSeq) LinksGSS LinksGSS (RefSeq) LinksNucleotide LinksNucleotide (RefSeq) LinksOMIA LinksOMIM (calculated) LinksOMIM (cited) LinksBioAssay LinksCompound LinksCompound via MeSHSubstance LinksSubstance via MeSHSubstance (Publisher) LinksPMC LinksCited in PMCPopSet LinksProbe LinksProtein LinksProtein (RefSeq) LinksProtein Cluster LinksSNP LinksStructure LinksTaxonomy via GenBankUniGene LinksUniSTS Links Show 5102050100200500Sort byPub DateFirst AuthorLast AuthorJournalSend toTextFilePrinterClipboardE-mailOrder





Write to the Help Desk
NCBI | NLM | NIH
Department of Health & Human Services
Privacy Statement | Freedom of Information Act | Disclaimer

Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

J Cyst Fibros. 2006 Jan; 5(1):33-41. Epub 2005 Nov 4.
 

rvm1212

New member
HI!
I have to say that I don´t agree with Amy when she sais "There isn't because genes don't predict how long you'll live. They simply don't. ".
How can you be so confident on that?? It´s difficult for me to think that a genetic disease progress has nothing to do with the type of gene you have. I know there are some articles where it sais that they couldn´t find that relationship yet. But that doesn´t mean it doesn´t exist. We don´t know much about cf genes yet to say that. Also there are some articles as the following one that don´t agree with that. By these I don´t mean that other things like exercise, chest therapy etc are not importat. I think it´s just a mix of everything.
I really hope a cure will be found soo. Let´s hope denufosol trial goes fine!!<img src="i/expressions/face-icon-small-smile.gif" border="0">



1: Thorax. 2005 Jul;60(7):558-63. Links
Genotype-phenotype correlation for pulmonary function in cystic fibrosis.de Gracia J, Mata F, Alvarez A, Casals T, Gatner S, Vendrell M, de la Rosa D, Guarner L, Hermosilla E.
Department of Pneumology, Hospital general Vall d'Hebron, Barcelona, Spain. jgracia@separ.es

BACKGROUND: Since the CFTR gene was cloned, more than 1000 mutations have been identified. To date, a clear relationship has not been established between genotype and the progression of lung damage. A study was undertaken of the relationship between genotype, progression of lung disease, and survival in adult patients with cystic fibrosis (CF). METHODS: A prospective cohort of adult patients with CF and two CFTR mutations followed up in an adult cystic fibrosis unit was analysed. Patients were classified according to functional effects of classes of CFTR mutations and were grouped based on the CFTR molecular position on the epithelial cell surface (I-II/I-II, I-II/III-V). Spirometric values, progression of lung disease, probability of survival, and clinical characteristics were analysed between groups. RESULTS: Seventy four patients were included in the study. Patients with genotype I-II/I-II had significantly lower current spirometric values (p < 0.001), greater loss of pulmonary function (p < 0.04), a higher proportion of end-stage lung disease (p < 0.001), a higher risk of suffering from moderate to severe lung disease (odds ratio 7.12 (95% CI 1.3 to 40.5)) and a lower probability of survival than patients with genotype I-II/III, I-II/IV and I-II/V (p < 0.001). CONCLUSIONS: <b><u><u>The presence of class I or II mutations on both chromosomes is associated with worse respiratory disease and a lower probability of survival</u></u></b>.

PMID: 15994263 [PubMed - indexed for MEDLINE]

Related LinksEuropean Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. [Pediatr Pulmonol. 2001]Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients. [Eur Respir J. 1996]Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. [Pediatrics. 2005]Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. [Lancet. 2003]Cystic fibrosis mutations and genotype-pulmonary phenotype analysis. [J Cyst Fibros. 2006]See all Related Articles...
Display SummaryBriefAbstractAbstractPlusCitationMEDLINEXMLUI ListLinkOutASN.1Related ArticlesCited ArticlesCited in BooksCancerChrom LinksDomain Links3D Domain LinksGEO DataSet LinksGene LinksGene (GeneRIF) LinksGenome LinksProject LinksGENSAT LinksGEO Profile LinksHomoloGene LinksCoreNucleotide LinksCoreNucleotide (RefSeq) LinksEST LinksEST (RefSeq) LinksGSS LinksGSS (RefSeq) LinksNucleotide LinksNucleotide (RefSeq) LinksOMIA LinksOMIM (calculated) LinksOMIM (cited) LinksBioAssay LinksCompound LinksCompound via MeSHSubstance LinksSubstance via MeSHSubstance (Publisher) LinksPMC LinksCited in PMCPopSet LinksProbe LinksProtein LinksProtein (RefSeq) LinksProtein Cluster LinksSNP LinksStructure LinksTaxonomy via GenBankUniGene LinksUniSTS Links Show 5102050100200500Sort byPub DateFirst AuthorLast AuthorJournalSend toTextFilePrinterClipboardE-mailOrder





Write to the Help Desk
NCBI | NLM | NIH
Department of Health & Human Services
Privacy Statement | Freedom of Information Act | Disclaimer

Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

J Cyst Fibros. 2006 Jan; 5(1):33-41. Epub 2005 Nov 4.
 

rvm1212

New member
HI!
I have to say that I don´t agree with Amy when she sais "There isn't because genes don't predict how long you'll live. They simply don't. ".
How can you be so confident on that?? It´s difficult for me to think that a genetic disease progress has nothing to do with the type of gene you have. I know there are some articles where it sais that they couldn´t find that relationship yet. But that doesn´t mean it doesn´t exist. We don´t know much about cf genes yet to say that. Also there are some articles as the following one that don´t agree with that. By these I don´t mean that other things like exercise, chest therapy etc are not importat. I think it´s just a mix of everything.
I really hope a cure will be found soo. Let´s hope denufosol trial goes fine!!<img src="i/expressions/face-icon-small-smile.gif" border="0">



1: Thorax. 2005 Jul;60(7):558-63. Links
Genotype-phenotype correlation for pulmonary function in cystic fibrosis.de Gracia J, Mata F, Alvarez A, Casals T, Gatner S, Vendrell M, de la Rosa D, Guarner L, Hermosilla E.
Department of Pneumology, Hospital general Vall d'Hebron, Barcelona, Spain. jgracia@separ.es

BACKGROUND: Since the CFTR gene was cloned, more than 1000 mutations have been identified. To date, a clear relationship has not been established between genotype and the progression of lung damage. A study was undertaken of the relationship between genotype, progression of lung disease, and survival in adult patients with cystic fibrosis (CF). METHODS: A prospective cohort of adult patients with CF and two CFTR mutations followed up in an adult cystic fibrosis unit was analysed. Patients were classified according to functional effects of classes of CFTR mutations and were grouped based on the CFTR molecular position on the epithelial cell surface (I-II/I-II, I-II/III-V). Spirometric values, progression of lung disease, probability of survival, and clinical characteristics were analysed between groups. RESULTS: Seventy four patients were included in the study. Patients with genotype I-II/I-II had significantly lower current spirometric values (p < 0.001), greater loss of pulmonary function (p < 0.04), a higher proportion of end-stage lung disease (p < 0.001), a higher risk of suffering from moderate to severe lung disease (odds ratio 7.12 (95% CI 1.3 to 40.5)) and a lower probability of survival than patients with genotype I-II/III, I-II/IV and I-II/V (p < 0.001). CONCLUSIONS: <b><u><u>The presence of class I or II mutations on both chromosomes is associated with worse respiratory disease and a lower probability of survival</u></u></b>.

PMID: 15994263 [PubMed - indexed for MEDLINE]

Related LinksEuropean Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. [Pediatr Pulmonol. 2001]Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients. [Eur Respir J. 1996]Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. [Pediatrics. 2005]Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. [Lancet. 2003]Cystic fibrosis mutations and genotype-pulmonary phenotype analysis. [J Cyst Fibros. 2006]See all Related Articles...
Display SummaryBriefAbstractAbstractPlusCitationMEDLINEXMLUI ListLinkOutASN.1Related ArticlesCited ArticlesCited in BooksCancerChrom LinksDomain Links3D Domain LinksGEO DataSet LinksGene LinksGene (GeneRIF) LinksGenome LinksProject LinksGENSAT LinksGEO Profile LinksHomoloGene LinksCoreNucleotide LinksCoreNucleotide (RefSeq) LinksEST LinksEST (RefSeq) LinksGSS LinksGSS (RefSeq) LinksNucleotide LinksNucleotide (RefSeq) LinksOMIA LinksOMIM (calculated) LinksOMIM (cited) LinksBioAssay LinksCompound LinksCompound via MeSHSubstance LinksSubstance via MeSHSubstance (Publisher) LinksPMC LinksCited in PMCPopSet LinksProbe LinksProtein LinksProtein (RefSeq) LinksProtein Cluster LinksSNP LinksStructure LinksTaxonomy via GenBankUniGene LinksUniSTS Links Show 5102050100200500Sort byPub DateFirst AuthorLast AuthorJournalSend toTextFilePrinterClipboardE-mailOrder





Write to the Help Desk
NCBI | NLM | NIH
Department of Health & Human Services
Privacy Statement | Freedom of Information Act | Disclaimer

Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

J Cyst Fibros. 2006 Jan; 5(1):33-41. Epub 2005 Nov 4.
 

rvm1212

New member
HI!
I have to say that I don´t agree with Amy when she sais "There isn't because genes don't predict how long you'll live. They simply don't. ".
How can you be so confident on that?? It´s difficult for me to think that a genetic disease progress has nothing to do with the type of gene you have. I know there are some articles where it sais that they couldn´t find that relationship yet. But that doesn´t mean it doesn´t exist. We don´t know much about cf genes yet to say that. Also there are some articles as the following one that don´t agree with that. By these I don´t mean that other things like exercise, chest therapy etc are not importat. I think it´s just a mix of everything.
I really hope a cure will be found soo. Let´s hope denufosol trial goes fine!!<img src="i/expressions/face-icon-small-smile.gif" border="0">



1: Thorax. 2005 Jul;60(7):558-63. Links
Genotype-phenotype correlation for pulmonary function in cystic fibrosis.de Gracia J, Mata F, Alvarez A, Casals T, Gatner S, Vendrell M, de la Rosa D, Guarner L, Hermosilla E.
Department of Pneumology, Hospital general Vall d'Hebron, Barcelona, Spain. jgracia@separ.es

BACKGROUND: Since the CFTR gene was cloned, more than 1000 mutations have been identified. To date, a clear relationship has not been established between genotype and the progression of lung damage. A study was undertaken of the relationship between genotype, progression of lung disease, and survival in adult patients with cystic fibrosis (CF). METHODS: A prospective cohort of adult patients with CF and two CFTR mutations followed up in an adult cystic fibrosis unit was analysed. Patients were classified according to functional effects of classes of CFTR mutations and were grouped based on the CFTR molecular position on the epithelial cell surface (I-II/I-II, I-II/III-V). Spirometric values, progression of lung disease, probability of survival, and clinical characteristics were analysed between groups. RESULTS: Seventy four patients were included in the study. Patients with genotype I-II/I-II had significantly lower current spirometric values (p < 0.001), greater loss of pulmonary function (p < 0.04), a higher proportion of end-stage lung disease (p < 0.001), a higher risk of suffering from moderate to severe lung disease (odds ratio 7.12 (95% CI 1.3 to 40.5)) and a lower probability of survival than patients with genotype I-II/III, I-II/IV and I-II/V (p < 0.001). CONCLUSIONS: <b><u><u>The presence of class I or II mutations on both chromosomes is associated with worse respiratory disease and a lower probability of survival</u></u></b>.

PMID: 15994263 [PubMed - indexed for MEDLINE]

Related LinksEuropean Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. [Pediatr Pulmonol. 2001]Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients. [Eur Respir J. 1996]Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. [Pediatrics. 2005]Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. [Lancet. 2003]Cystic fibrosis mutations and genotype-pulmonary phenotype analysis. [J Cyst Fibros. 2006]See all Related Articles...
Display SummaryBriefAbstractAbstractPlusCitationMEDLINEXMLUI ListLinkOutASN.1Related ArticlesCited ArticlesCited in BooksCancerChrom LinksDomain Links3D Domain LinksGEO DataSet LinksGene LinksGene (GeneRIF) LinksGenome LinksProject LinksGENSAT LinksGEO Profile LinksHomoloGene LinksCoreNucleotide LinksCoreNucleotide (RefSeq) LinksEST LinksEST (RefSeq) LinksGSS LinksGSS (RefSeq) LinksNucleotide LinksNucleotide (RefSeq) LinksOMIA LinksOMIM (calculated) LinksOMIM (cited) LinksBioAssay LinksCompound LinksCompound via MeSHSubstance LinksSubstance via MeSHSubstance (Publisher) LinksPMC LinksCited in PMCPopSet LinksProbe LinksProtein LinksProtein (RefSeq) LinksProtein Cluster LinksSNP LinksStructure LinksTaxonomy via GenBankUniGene LinksUniSTS Links Show 5102050100200500Sort byPub DateFirst AuthorLast AuthorJournalSend toTextFilePrinterClipboardE-mailOrder





Write to the Help Desk
NCBI | NLM | NIH
Department of Health & Human Services
Privacy Statement | Freedom of Information Act | Disclaimer

Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

J Cyst Fibros. 2006 Jan; 5(1):33-41. Epub 2005 Nov 4.
 

rvm1212

New member
HI!
I have to say that I don´t agree with Amy when she sais "There isn't because genes don't predict how long you'll live. They simply don't. ".
How can you be so confident on that?? It´s difficult for me to think that a genetic disease progress has nothing to do with the type of gene you have. I know there are some articles where it sais that they couldn´t find that relationship yet. But that doesn´t mean it doesn´t exist. We don´t know much about cf genes yet to say that. Also there are some articles as the following one that don´t agree with that. By these I don´t mean that other things like exercise, chest therapy etc are not importat. I think it´s just a mix of everything.
I really hope a cure will be found soo. Let´s hope denufosol trial goes fine!!<img src="i/expressions/face-icon-small-smile.gif" border="0">



1: Thorax. 2005 Jul;60(7):558-63. Links
Genotype-phenotype correlation for pulmonary function in cystic fibrosis.de Gracia J, Mata F, Alvarez A, Casals T, Gatner S, Vendrell M, de la Rosa D, Guarner L, Hermosilla E.
Department of Pneumology, Hospital general Vall d'Hebron, Barcelona, Spain. jgracia@separ.es

BACKGROUND: Since the CFTR gene was cloned, more than 1000 mutations have been identified. To date, a clear relationship has not been established between genotype and the progression of lung damage. A study was undertaken of the relationship between genotype, progression of lung disease, and survival in adult patients with cystic fibrosis (CF). METHODS: A prospective cohort of adult patients with CF and two CFTR mutations followed up in an adult cystic fibrosis unit was analysed. Patients were classified according to functional effects of classes of CFTR mutations and were grouped based on the CFTR molecular position on the epithelial cell surface (I-II/I-II, I-II/III-V). Spirometric values, progression of lung disease, probability of survival, and clinical characteristics were analysed between groups. RESULTS: Seventy four patients were included in the study. Patients with genotype I-II/I-II had significantly lower current spirometric values (p < 0.001), greater loss of pulmonary function (p < 0.04), a higher proportion of end-stage lung disease (p < 0.001), a higher risk of suffering from moderate to severe lung disease (odds ratio 7.12 (95% CI 1.3 to 40.5)) and a lower probability of survival than patients with genotype I-II/III, I-II/IV and I-II/V (p < 0.001). CONCLUSIONS: <b><u><u>The presence of class I or II mutations on both chromosomes is associated with worse respiratory disease and a lower probability of survival</u></u></b>.

PMID: 15994263 [PubMed - indexed for MEDLINE]

Related LinksEuropean Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. [Pediatr Pulmonol. 2001]Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients. [Eur Respir J. 1996]Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. [Pediatrics. 2005]Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. [Lancet. 2003]Cystic fibrosis mutations and genotype-pulmonary phenotype analysis. [J Cyst Fibros. 2006]See all Related Articles...
Display SummaryBriefAbstractAbstractPlusCitationMEDLINEXMLUI ListLinkOutASN.1Related ArticlesCited ArticlesCited in BooksCancerChrom LinksDomain Links3D Domain LinksGEO DataSet LinksGene LinksGene (GeneRIF) LinksGenome LinksProject LinksGENSAT LinksGEO Profile LinksHomoloGene LinksCoreNucleotide LinksCoreNucleotide (RefSeq) LinksEST LinksEST (RefSeq) LinksGSS LinksGSS (RefSeq) LinksNucleotide LinksNucleotide (RefSeq) LinksOMIA LinksOMIM (calculated) LinksOMIM (cited) LinksBioAssay LinksCompound LinksCompound via MeSHSubstance LinksSubstance via MeSHSubstance (Publisher) LinksPMC LinksCited in PMCPopSet LinksProbe LinksProtein LinksProtein (RefSeq) LinksProtein Cluster LinksSNP LinksStructure LinksTaxonomy via GenBankUniGene LinksUniSTS Links Show 5102050100200500Sort byPub DateFirst AuthorLast AuthorJournalSend toTextFilePrinterClipboardE-mailOrder





Write to the Help Desk
NCBI | NLM | NIH
Department of Health & Human Services
Privacy Statement | Freedom of Information Act | Disclaimer

Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

J Cyst Fibros. 2006 Jan; 5(1):33-41. Epub 2005 Nov 4.
 

rvm1212

New member
HI!
I have to say that I don´t agree with Amy when she sais "There isn't because genes don't predict how long you'll live. They simply don't. ".
How can you be so confident on that?? It´s difficult for me to think that a genetic disease progress has nothing to do with the type of gene you have. I know there are some articles where it sais that they couldn´t find that relationship yet. But that doesn´t mean it doesn´t exist. We don´t know much about cf genes yet to say that. Also there are some articles as the following one that don´t agree with that. By these I don´t mean that other things like exercise, chest therapy etc are not importat. I think it´s just a mix of everything.
I really hope a cure will be found soo. Let´s hope denufosol trial goes fine!!<img src="i/expressions/face-icon-small-smile.gif" border="0">



1: Thorax. 2005 Jul;60(7):558-63. Links
Genotype-phenotype correlation for pulmonary function in cystic fibrosis.de Gracia J, Mata F, Alvarez A, Casals T, Gatner S, Vendrell M, de la Rosa D, Guarner L, Hermosilla E.
Department of Pneumology, Hospital general Vall d'Hebron, Barcelona, Spain. jgracia@separ.es

BACKGROUND: Since the CFTR gene was cloned, more than 1000 mutations have been identified. To date, a clear relationship has not been established between genotype and the progression of lung damage. A study was undertaken of the relationship between genotype, progression of lung disease, and survival in adult patients with cystic fibrosis (CF). METHODS: A prospective cohort of adult patients with CF and two CFTR mutations followed up in an adult cystic fibrosis unit was analysed. Patients were classified according to functional effects of classes of CFTR mutations and were grouped based on the CFTR molecular position on the epithelial cell surface (I-II/I-II, I-II/III-V). Spirometric values, progression of lung disease, probability of survival, and clinical characteristics were analysed between groups. RESULTS: Seventy four patients were included in the study. Patients with genotype I-II/I-II had significantly lower current spirometric values (p < 0.001), greater loss of pulmonary function (p < 0.04), a higher proportion of end-stage lung disease (p < 0.001), a higher risk of suffering from moderate to severe lung disease (odds ratio 7.12 (95% CI 1.3 to 40.5)) and a lower probability of survival than patients with genotype I-II/III, I-II/IV and I-II/V (p < 0.001). CONCLUSIONS: <b><u><u>The presence of class I or II mutations on both chromosomes is associated with worse respiratory disease and a lower probability of survival</u></u></b>.

PMID: 15994263 [PubMed - indexed for MEDLINE]

Related LinksEuropean Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. [Pediatr Pulmonol. 2001]Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients. [Eur Respir J. 1996]Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. [Pediatrics. 2005]Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. [Lancet. 2003]Cystic fibrosis mutations and genotype-pulmonary phenotype analysis. [J Cyst Fibros. 2006]See all Related Articles...
Display SummaryBriefAbstractAbstractPlusCitationMEDLINEXMLUI ListLinkOutASN.1Related ArticlesCited ArticlesCited in BooksCancerChrom LinksDomain Links3D Domain LinksGEO DataSet LinksGene LinksGene (GeneRIF) LinksGenome LinksProject LinksGENSAT LinksGEO Profile LinksHomoloGene LinksCoreNucleotide LinksCoreNucleotide (RefSeq) LinksEST LinksEST (RefSeq) LinksGSS LinksGSS (RefSeq) LinksNucleotide LinksNucleotide (RefSeq) LinksOMIA LinksOMIM (calculated) LinksOMIM (cited) LinksBioAssay LinksCompound LinksCompound via MeSHSubstance LinksSubstance via MeSHSubstance (Publisher) LinksPMC LinksCited in PMCPopSet LinksProbe LinksProtein LinksProtein (RefSeq) LinksProtein Cluster LinksSNP LinksStructure LinksTaxonomy via GenBankUniGene LinksUniSTS Links Show 5102050100200500Sort byPub DateFirst AuthorLast AuthorJournalSend toTextFilePrinterClipboardE-mailOrder





Write to the Help Desk
NCBI | NLM | NIH
Department of Health & Human Services
Privacy Statement | Freedom of Information Act | Disclaimer

Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

J Cyst Fibros. 2006 Jan; 5(1):33-41. Epub 2005 Nov 4.
 

Diane

New member
Im not so sure about the gene thing myself. I dont know too much about how all that works. But i will tell you, i also was very mild pretty much all my young life. I had very high pft's till i got cepacia in my 30's. I have learned that the most important thing to keep in mind is prevention. Dont worry so much about which gene will do what, and how long one will live, ( after all walking out the front door everyday is a risk) Instead try to focus on keeping him healthy by any means possible. If he has to be hospitalized, wipe everything down in the hospital room with sanitary wipes or alcohol ( i got cepacia from being in the hospital), keep distance from anyone whos' sick, make sure he does all his meds and stays active.
 

Diane

New member
Im not so sure about the gene thing myself. I dont know too much about how all that works. But i will tell you, i also was very mild pretty much all my young life. I had very high pft's till i got cepacia in my 30's. I have learned that the most important thing to keep in mind is prevention. Dont worry so much about which gene will do what, and how long one will live, ( after all walking out the front door everyday is a risk) Instead try to focus on keeping him healthy by any means possible. If he has to be hospitalized, wipe everything down in the hospital room with sanitary wipes or alcohol ( i got cepacia from being in the hospital), keep distance from anyone whos' sick, make sure he does all his meds and stays active.
 

Diane

New member
Im not so sure about the gene thing myself. I dont know too much about how all that works. But i will tell you, i also was very mild pretty much all my young life. I had very high pft's till i got cepacia in my 30's. I have learned that the most important thing to keep in mind is prevention. Dont worry so much about which gene will do what, and how long one will live, ( after all walking out the front door everyday is a risk) Instead try to focus on keeping him healthy by any means possible. If he has to be hospitalized, wipe everything down in the hospital room with sanitary wipes or alcohol ( i got cepacia from being in the hospital), keep distance from anyone whos' sick, make sure he does all his meds and stays active.
 

Diane

New member
Im not so sure about the gene thing myself. I dont know too much about how all that works. But i will tell you, i also was very mild pretty much all my young life. I had very high pft's till i got cepacia in my 30's. I have learned that the most important thing to keep in mind is prevention. Dont worry so much about which gene will do what, and how long one will live, ( after all walking out the front door everyday is a risk) Instead try to focus on keeping him healthy by any means possible. If he has to be hospitalized, wipe everything down in the hospital room with sanitary wipes or alcohol ( i got cepacia from being in the hospital), keep distance from anyone whos' sick, make sure he does all his meds and stays active.
 
Top